Skip to main content
European Stroke Journal logoLink to European Stroke Journal
. 2026 May 6;11(Suppl 1):i780. doi: 10.1093/esj/aakag023.1431

ABSTRACT NUMBER: ESOC2026A848 ALLOCENTRIC NEGLECT ALEXIA CORRELATSES WITH ALLOCENTRIC VISUAL NEGLECT AT THE ACUTE PHASE OF STROKE

Jean-Baptiste Brunet de Courssou 1,2, Elodie Ansquin 3, Anne-Claire Tissier 4, Sandrine Deltour 5,6
PMCID: PMC13145539

Abstract

Background and aims

Neglect alexia (NA) is part of spatial neglect (SN) syndrome. Allocentric NA affects letters on the left or right side of words relative to the patient’s point of view. We aimed at describing it and its association with visual neglect.

Methods

We perform in routine care SN assessment in patients with acute phase stroke, using the Apples cancelation test (ACT) and words/pseudowords reading test. We report the results for patients who had no prior history of stroke or cognitive impairment.

Results

We included 120 patients. The mean initial NIHSS score was 3.9 ± 4.2. Right-sided strokes occurred in 49 % (59/120) of patients, bilateral strokes in 10 % (12/120). Strokes were supratentorial in 76 % (91/120) and involved both supra- and infratentorial regions in 8 % (n = 9).

Forty-five percent (54/120) of patients exhibited either allocentric or egocentric visual neglect on the ACT. Both subtypes co-occurred in 12 patients, of whom nine showed a consistent right- or left-sided visual-neglect lateralisation. No diagnostic cut-off exists for allocentric NA. Nevertheless, allocentric NA scores differed significantly (p = 0.011) between right- and left-supratentorial strokes. Allocentric NA scores were significantly associated with allocentric visual-neglect scores (p = 0.001), although the correlation was weak (R2 = 0.08).

Conclusions

We confirm the presence of allocentric NA after stroke. Its weak correlation with allocentric visual neglect suggests a clinical dissociation between these two manifestations of spatial neglect and implies that the underlying neuronal networks only partially overlap, as previously reported.

Conflict of interest

Brunet de Courssou: institutional funding from Novartis through the Novartis–SFN BRAINNS (Bourses de Recherche pour l’Avancement de l’Innovation en Neurosciences) research grant program. The other authors have nothing to disclose.


Articles from European Stroke Journal are provided here courtesy of Oxford University Press

RESOURCES